Report: Fujifilm plans to buy Hitachi imaging business

Fujifilm is planning to acquire the medical imaging business of Hitachi in...Read more on AuntMinnie.comRelated Reading: Fujifilm to debut glass-free DR panel at RSNA 2019 Hitachi delivers proton therapy unit to Sibley Memorial Fujifilm unveils new Synapse Cardiology PACS release Fujifilm wins 3 new enterprise imaging clients Hitachi takes order for particle therapy system Hitachi features CT, MRI technology at ECR 2019
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

The outcome of chordoma patients with local or distant failure after proton therapy is not well established. We assessed the disease-specific (DSS) and overall survival of patients recurring after proton therapy and evaluated the prognostic factors affecting DSS.
Source: Clinical Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research
CONCLUSIONS: This work demonstrated the feasibility of using sCT generated with a GAN-based deep learning method for MRI-only treatment planning of patients with brain tumor in intensity-modulated proton therapy. PMID: 32216098 [PubMed - as supplied by publisher]
Source: Journal of Applied Clinical Medical Physics - Category: Physics Authors: Tags: J Appl Clin Med Phys Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
Abstract Positron emission tomography and prompt gamma detection are promising proton therapy monitoring modalities. Fast calculation of the expected distributions is desirable for comparison to measurements and to develop/train algorithms for automatic treatment error detection. A filtering formalism was used for positron-emitter predictions and adapted to allow for its use for the beamline of any proton therapy centre. A novel approach based on a filtering formalism was developed for the prediction of energy-resolved prompt-gamma distributions for arbitrary tissues. The method estimates prompt-gamma yields and t...
Source: Physics in Medicine and Biology - Category: Physics Authors: Tags: Phys Med Biol Source Type: research
PALO ALTO, Calif., March 17, 2020 -- (Healthcare Sales &Marketing Network) -- Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam® Compact proton therapy system. The center,... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
Radiation therapy (RT) of thoracic cancers may cause severe radiation dermatitis (RD), which impacts on the quality of a patient's life. Aim of this study was to analyze the incidence of acute RD and develop normal tissue complication probability (NTCP) models for severe RD in thoracic cancer patients treated with Intensity-Modulated RT (IMRT) or Passive Scattering Proton Therapy (PSPT). We analyzed 166 Non-Small-Cell Lung Cancer (NSCLC) patients prospectively treated at a single institution with IMRT (103 patients) or PSPT (63 patients). All patients were treated to a prescribed dose of 60 to 74 Gy in conventional daily f...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
This study evaluated the measurements of proton pencil beam scanning delivery made with a 2D ion chamber array in solid water on a 1D motion platform, where respiratory motion was simulated using sine and cosine4 waves representing sinusoidal symmetric and realistic asymmetric breathing motions, respectively. Motion amplitudes were 0.5 cm and 1 cm corresponding to 1 cm and 2 cm of maximum respiratory excursions, respectively, with 5 sec fixed breathing cycle. The treatment plans were created to mimic spherical targets of 3 cm or 10 cm diameter located at 5 cm or 1 cm depth in so...
Source: Journal of Applied Clinical Medical Physics - Category: Physics Authors: Tags: J Appl Clin Med Phys Source Type: research
To report control and toxicity outcomes for patients with adenoid cystic carcinoma (ACC) of the non-skull base head and neck treated at a single institution with proton therapy.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Non-squamous Cell Malignancies of the Head and Neck: thyroid, sarcomas, skin cancers, salivary gland and sinus cancers Source Type: research
We report our dosimetric and clinical outcomes in terms of disease control and toxicity in patients with parotid gland malignancies treated with IMPT.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Non-squamous Cell Malignancies of the Head and Neck: thyroid, sarcomas, skin cancers, salivary gland and sinus cancers Source Type: research
To assess the outcomes and toxicities for squamous cell carcinoma (SCC) of the larynx treated with proton therapy.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Toxicity, Quality of Life, Survivorship, Costs of Care Source Type: research
More News: Cardiology | Heart | Proton Therapy | Radiology